A search for "Mylan patient assistance Yupelri" suggests that individuals are seeking information on how to access Yupelri with financial assistance programs offered by Mylan, now known as Viatris.
How Can I Get Yupelri with Mylan Patient Assistance?
For patients prescribed Yupelri (revefenacin) who need assistance with costs, Mylan, which is now part of Viatris, historically offered patient assistance programs. These programs are designed to help eligible uninsured or underinsured patients afford their medications. To find out about current Yupelri patient assistance options through Viatris, individuals should visit the Viatris website or contact their patient support services directly. Information about medication assistance programs is typically found in a dedicated section of the company's site.
What Is Yupelri and What Does It Treat?
Yupelri is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) [1]. It is administered via a nebulizer and works by relaxing the muscles around the airways, making it easier to breathe [1].
When Does Yupelri Patent Expiry?
Information regarding the patent expiry for Yupelri can be found through resources that track drug patents. DrugPatentWatch.com provides data on pharmaceutical patents, which would include details on Yupelri's intellectual property protection [2]. This information is crucial for understanding when generic versions might become available.
Who Manufactures Yupelri?
Yupelri was developed by Theravance Biopharma and is marketed by Mylan, which is now Viatris [3][1]. Therefore, Viatris is the current manufacturer and distributor responsible for the drug.
What Are the Alternatives to Yupelri for COPD?
Other treatments for COPD include different classes of bronchodilators such as long-acting beta-agonists (LABAs), combination inhalers (LABA/LAMA), and inhaled corticosteroids (ICS) in certain patients [4]. The choice of treatment depends on the individual's symptom severity, disease progression, and response to therapy.
How Is Yupelri Administered?
Yupelri is delivered using a standard jet nebulizer and a mouthpiece or mask [1]. It is typically taken once daily.
What Are the Side Effects of Yupelri?
Common side effects of Yupelri include runny nose, sore throat, cough, and back pain [1]. More serious side effects can include urinary retention and angle-closure glaucoma. Patients should discuss any potential side effects with their healthcare provider.
Where Can I Find More Information on Yupelri?
Detailed prescribing information and resources for patients and healthcare professionals about Yupelri are available through the Viatris website and through medical information portals.
Sources
1. Yupelri Prescribing Information
2. DrugPatentWatch.com
3. Theravance Biopharma Press Release
4. National Heart, Lung, and Blood Institute